Opiates
to
download as a PDF file click here
About
this fact sheet:
This fact
sheet is about opiates and opioids that
may be encountered by drug users and workers. HEROIN and METHADONE
are considered in their own sheets. So this Fact Sheet doesn’t consider
these compounds. Most of the compounds here are used medicinally,
but may also be the subject of non-medical use.
For the sake of completeness, OPIUM is included in this section.
Opiate or opioid?
Semantically,
OPIATES are compounds present in the OPIUM POPPY (Papaver
Somniferum) extracted and refined. OPIOIDS
are synthetic or semi-synthetic compounds which have similar chemical
or pharmacological effects.
So morphine is an opiate, because it is a compound present in the
opium poppy. Diamorphine is an opioid, as it
is a semi-synthetic compound derived from morphine; methadone is an
opioid and is wholly synthetic.
The term
opiates and opioids are often used interchangeably.
For convenience the term opioids will be
used throughout this paper.
The compounds
are presented alphabetically.
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
ALFENTANIL
|
CD:
POM
Classs A, Sch.2
|
Mainly
used in surgery
|
|
Rapifen
|
|
Notes:
Powerful analogue of fentanyl; strong respiratory
suppression.
Not known as a street drug.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
BUPRENORPHINE
|
CD:
POM
Class C, Sch.3
|
Moderate
to severe pain
Treatment
for heroin dependency
|
|
Temgesic, Subutex
temmies, subbies,
bupe
|
|
Notes:
Buprenorphine is a partial opiate agonist; it is a potent
pain-killer. It binds powerfully to specific opiate receptors,
but only partially activates these receptors hence the “partial
agonist” name. This characteristic means that doses of buprenorphine
can be given to fill opiate receptors, blocking other opiates
(such as heroin) from working at them but with less risk of
an opiate overdose.
The net result
for the user is that, if buprenorphine
is taken correctly at a sufficiently high dose, other opiates
used “on top” won’t work, and so such use on top should be reduced.
In practice, “use on top” may take the form of drinking or use
of benzos, neither of which is blocked by burprenorphine.
Buprenorphine will compete with other opiates, such as
heroin and methadone, and if these compounds are present at
receptor sites, buprenorphine is likely to displace them. This can mean
that a user with heroin in their system may experience withdrawal
effects when they take buprenorphine
as the full agonist (heroin, methadone) is displaced by the
partial agonist.
However, if someone who has no opiates in their system takes
buprenorphine, they can and do get a significant level of
opiate reward – less intense than heroin, but sufficient to
warrant buprenorphine having a street value as a drug of misuse.
Buprenorphine causes less respiratory suppression than
heroin or methadone and so the risk of overdose is lower. However
people can and do overdose on buprenorphine.
Naloxone is not wholly effective at reversing buprenorphine overdoses. Overdose is more likely where burprenorphine has been snorted or injected.
Buprenorphine is still an opiate with attendant issues
of addiction and withdrawal. It is also constipating. Some users
find that it provides a better level of clarity of thought than
methadone; while some people find this aspect beneficial, others
don’t like the new clear-headedness that buprenorphine
provides.
Buprenorphine is generally prescribed and dispensed for
sublingual administration. It is powerfully broken down by the
liver so swallowing buprenorphine
is highly ineffective. However, even when taken sublingually,
it is likely that bioavailability is only around 33%.
This level of availability goes up if the drug is crushed and
snorted, and goes up higher still if injected. This has seen
a huge increase in the administration of buprenorphine
by these routes.
Buprenorphine tablets, under the brand-name Temgesic were widely used as an illicit drug, especially
in Scotland. They were typically
crushed and injected. At this time it was primarily marketed
as a low dose tablet for pain relief.
However, it was
when it was reformulated and rebranded
as Subutex that interest in the drug really took off. It has
been used extensively in France since 1996,
and became a lynchpin of the US prescribing
system, being the only opiate-substitute that can be dispensed
away from specialist clinics.
Buprenorphine started to gain acceptance in the UK as a treatment
from around 1999, and has become an increasingly popular alternative
to methadone.
In some parts
of the UK, cost of branded
Subutex has meant it was less widely
available than its cheaper rival, Methadone. However, with the
patent for Subutex now over, there is scope for cheaper generics to
hit the market.
In an effort to discourage diversion and non-intended use, Schering
Plough is marketing “Suboxone,” its
new, licensed product. See separate entry on Suboxone.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
CO-CODAMOL
|
OTC
– low dose
POM – higher dose
|
Mixture
of codeine phosphate and paracetamol.
Treatment of mild to moderate pain
|
|
Paracodol, Solpadol
|
|
Notes:
Available in a variety of strengths, ranging from 8:500 (8mg codeine
to 500mg paracetamol) through to 30:500.
Small quantities of 8:500mg formulations are available as an
OTC but high strength formulations require a prescription.
Tolerance and dependency on codeine can develop with constant use, and
there is a risk that people will escalate their dose. Codeine
can also cause severe constipation.
The key risk of abuse of co-codamol is liver
damage stemming from the high intake of paracetamol,
and so people taking excessive quantities of co-codamol
expose themselves to risk of liver damage.
Some preparations contain methionine which
may prevent paracetamol-induced liver
toxcicity.
|
|
Names
|
Class/Schedule
|
Description/Primary Uses
|
|
CO-DYDRAMOL
|
OTC
- low dose
POM
– higher dose
|
Mixture
of dihydrocodeine and paracetamol
Mild
to moderate pain
|
|
Paramol
|
|
Comments: A compound analagesic combining the opiate pain killer dihydrocodeine tartrate with the
analgesic paracetamol. Available in
a range of strengths; the weakest is mixed at a strength of
7.46mg dihydrocodeine to 500mg paracetamol.
In this form it is available as an OTC medicine sold as Paramol.
Stronger versions, mixed at 10, 20 and 30mg dihydrocodeine
to 500mg paracetamol are POMs.
As with cocodamol, excessive doses
of co-dydramol bring with it significant risk of liver damage
through paracetamol toxcicity.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
CO-PHENOTROPE
|
OTC
– low dose
POM – higher dose
|
Diarrhoea
treatment:
Mixture of diphenoxylate hydrochloride
and atropine
|
|
Lomototil; Dymotil
|
|
Notes:
The opiate part, which is structurally similar to pethidine
and slows down gut movement. It has the potential for dependency
and misuse. To reduce these risks, it is sold in combination
with atropine which in higher doses can cause severe negative
side-effects such as irregular heart beat, double vision, nausea
and agitation.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
CO-PROXAMOL
|
POM
|
Mixture
of detropropoxyphene hydrochloride
and paracetamol
Mild to moderate pain
|
|
Distalgesics
|
|
Notes:
The opioid analagesic
dextropropoxyphene is a relatively
weak painkiller but can be dangerous in overdose, and can cause
mood-swings and arrythmias, and is especially dangerous in combination with
alcohol.
Due to these risks, and
its relatively low therapeutic index some argue that
it is no more effective than the paracetamol
with which it is combined its legal status in the Uk was reviewed
in 2004. It was decided to stage a staggered withdrawal of the
drug with a view to it being removed from the market. At the
time of writing it is still available but on a limited basis,
typically on a ‘named patient basis.’.
|
|
Names
|
Class/Schedule
|
Description/Primary Uses
|
|
CODEINE
PHOSPHATE
|
CD;
Class
A; Sch 2 in injectable
form
Class
B: Sch 5 in non injectable
form
|
Pain
relief – used alone or in compounds with other analgesics
Cough relief
|
|
Found
in: Feminax, Solpadeine,
Panadol Ultra as a compound analgesic
|
|
Notes:
effective in the treatment of mild to moderate pain relief but causes
significant constipation. Has the potential to cause dependency
and is subject to non-medical use.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
DEXTROMORPHAN
HYDROBROMIDE
|
OTCs
|
Used
in many cough-relief preparations.
|
|
In:
Actifed, benylin:
|
|
Notes:
Dextromethorphan is used in many
cough medicines for its anti-tussive
effects. It is derived from an opioid
leverpharnol, but doesn’t exhibit
opiate type effects such as euphoria or sedation. Indeed it
may inhibit the action of other opiates.
However, in high doses, Dextromethorphan
can cause dissassociative hallucinations and when misused in this
way has similar effects to Ketamine.
Misuse in this way has been uncommon in the UK, but has been
a significant cause of concern in the USA, where access
to compounds containing dextromorphan
has been restricted to reduce abuse.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
DIAMORPHINE
HYDROCHLORIDE
|
CD:
Class A, Sch.2
|
Pharmaceutically
pure heroin hydrochloride:
Severe
pain relief; treatment of dependency
|
|
Diagesil, Diaphine
|
|
Notes:
Pharmaceutical grade heroin, produced from morphine through reaction
with acetic anhydride.
In the sixties this drug was prescribed quite widely to opiate
dependent people, but following review of drug laws and prescribing
practice, prescribing for addiction is now much less common.
Contrary to media confusion on the subject, it has always been
lawful to “prescribe heroin on the NHS.” It is most commonly
used for severe pain relief in hospital settings. However, GPs
can undertake additional training and seek a Home Office licence
to prescribe diamorphine for the treatment
of addiction.
It is prescribed
in injectable form, either pre-dissolved
(‘wet amps’) or for dissolving in sterile water (‘dry amps.’)
Currently, prescribing takes place across the UK to a number
of individuals. A small number of clinical trials have been
established to assess how effective this model of treatment
is and early reports (November 1997) are encouraging.
However, due
to its relatively short period of effect, risks of diversion,
and the need to continue injecting, it remains the least widely
used opiate substitute treatment.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
DEXTROMORAMIDE
|
CD:
Class A , Sch.2
(discontinued in UK 2003)
|
For
severe and intractable pain-relief:
|
|
Palfium Peach Palfs
|
|
Notes: Dextromoramide is a powerful pain killer with a high potential
for overdose and misuse. It is the subject of control internationally.
It is no longer prescribed in the UK though this
was because of difficulty sourcing the precursors and the drug
reliably rather than due to misuse.
Historically, 5mg and 10mg Palfium
(Peach Palfs) were a highly-sought opiate, often injected.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
DEXTROPROPOXYPHENE
HYDROCHLORIDE
|
POM
|
Mild
to moderate pain relief
|
|
Constituent
of: co-proxamol, costalgesic,
distalgesic, dolxene
|
|
Notes:
The opioid analagesic
dextropropoxyphene is a relatively
weak painkiller but can be dangerous in overdose, and can cause
mood-swings and arrythmias, and is especially dangerous in combination with
alcohol. See entry on Co-proxamol
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
DIHYDROCODEINE
TARTRATE
|
CD:
Class B, Sch.2/5
Depends on formulation
Class
A in injectable form
|
Moderate
to severe pain relief
|
|
DF118,
DFs
DHC Continue
|
|
Notes:
Dihydrocodeine is a relatively
popular opiate in the UK; it is not as
potent as morphine or heroin, but can provide good pain relief.
It has often been considered a reasonably good “standby” for
opiate users self-medicating through withdrawal or as a street
drug if stronger opiates weren’t available.
It is available as an OTC as co-drydamol.
Stronger preparations are a Schedule 2 drug, and in injectable
form it is a Class A, Schedule 2 drug.
Internationally, especially on mainland Europe, tablets containing
dihydrocodeine are available as a
wax-bound sustained-release tablet. These are currently not
common in the UK. Attempts to
inject such wax-based tablets are likely to result in severe
injecting complications.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
DIPIPANONE
|
CD:
Class A, Sch.2
|
Moderate
to severe pain relief
|
|
Diconal – dipipanone and
Cyclizine
Dikes, Pinks, Strawberry Milkshake
|
|
Notes:
Structurally similar to methadone, dipinanone
is a powerful opiate. It tends to cause a high level of nausea
so it was combined in tablet form with the anti-emetic (anti-nausea)
drug cyclizine. The snag was that the two drugs, crushed and
injected, provided a powerful and intense rush, leading to the
drug being highly popular on the illicit market.
To add to the
problems, diconal was formulated with
tiny silicon particles that would block veins leading to tissue
loss, and amputations. A significant number of older injectors
lost digits or limbs through the injection of diconal.
Although still
licensed in the UK, diconal rarely appears as a street drug now.
|
|
Names
|
Class/Schedule
|
Description/Primary
Uses
|
|
FENTANYL
|
CD:
Class A, Sch.2
|
Severe
pain;
Breakthrough-pain
in opiate dependent patients;
anaesthesia
|
|
Durogesic
|
|
Notes: Fentanyl is a powerful opiate analgesic, some 80 times more
potent that morphine. It’s main use
is on hospital settings for severe and chronic pain. It is also
used in anaesthesia.
There are a number of analogues of Fentanyl,
including:
Alfentanil (short acting 5-10 mins),
Sufentanil (10x potency of Fentanyl),
Remifentanil (shortest acting) and
Carfentanil (10,000x potency of methadone: can quite literally
put down an elephant and indeed is used to do so).
Fentanyl crops up as a significant
street drug in the States, where it is diverted from medical
supplies or , less commonly manufactured
in underground labs.
Fentanyl comes in Transdermal
patches, and also in lollipops or lozenges for oral consumption.
It may be extracted from patches and injected, or sold in powder
form for snorting or injection.
Reports suggest that Fentanyl offers
a less euphoric high but is a more potent respiratory suppressant
and so is a key risk in overdose. It is comparatively short
acting, leading to more frequent use. Tolerance to heroin does
not equate to tolerance to fentanyl
and this, combined with the increased potency of fentanyl,
means that even opiate-dependent users are at risk of fentanyl
overdoses.
At present, use in the UK is not widespread, and the extraction of
fentanyl from patches can be a messy and wasteful process. However,
there is every chance that misuse of Fentanyl
will increase in the UK, and bring with it an increase in overdoses.
|
|
Names
|
| |